See analyst estimates and all valuation multiples for Pharmacies
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $173B | 0.4x | 10.7x | |
| $27.3B | 7.7x | 31.6x | |
| $24.1B | n/a | n/a | |
| $18.6B | 1.9x | 42.2x | |
| $11.8B | 0.3x | 5.3x | |
| $11.3B | 2.4x | 38.7x | |
| $8.5B | 0.7x | 14.2x | |
| $7.6B | 0.9x | 12.1x | |
| $7.0B | 1.0x | 9.9x | |
| $5.2B | 1.8x | 13.6x | |
| $4.3B | 1.6x | 9.5x | |
| $4.2B | 0.5x | 10.9x | |
| $4.0B | 0.5x | 9.3x | |
| $3.9B | 0.6x | 8.6x | |
| $3.9B | 1.1x | 9.2x | |
| $3.8B | 0.6x | 9.0x | |
| $3.8B | 0.6x | 8.5x | |
| $3.6B | 0.2x | 5.2x | |
| $3.2B | 0.6x | 7.4x | |
| $3.0B | 0.8x | 7.0x | |
| $3.0B | 0.8x | 11.4x | |
| $2.7B | 0.4x | 4.9x | |
| $2.2B | 0.7x | 6.8x | |
| $2.1B | 1.2x | 8.5x | |
| $2.0B | 0.6x | 29.3x | |
| $2.0B | 0.6x | 29.3x | |
| $2.0B | 0.8x | 10.0x | |
| $1.6B | 0.5x | 6.3x | |
| $1.6B | 2.0x | 6.2x | |
| $1.4B | 1.2x | 10.2x | |
| $1.2B | 0.9x | 10.5x | |
| $1.2B | 0.4x | n/a | |
| $1.1B | 1.5x | 18.3x | |
| $1.1B | 0.4x | 7.0x | |
| $1.1B | 0.4x | 8.1x | |
| $1.1B | n/a | n/a | |
| $1.0B | 0.3x | 8.1x | |
| $994M | n/a | n/a | |
| $986M | n/a | n/a | |
| $819M | n/a | n/a | |
| $703M | n/a | n/a | |
| $700M | 1.1x | 12.8x | |
| $690M | 0.2x | 24.7x | |
| $614M | n/a | n/a | |
| $587M | n/a | n/a | |
| $447M | 0.4x | 6.3x | |
| $427M | 0.3x | -7.4x | |
| $398M | n/a | n/a | |
| $313M | n/a | n/a | |
| $303M | 0.2x | n/a | |
| $300M | 0.7x | 11.8x | |
| $135M | n/a | n/a | |
| $115M | n/a | n/a | |
| $84.9M | 0.6x | 23.4x | |
| $82.1M | n/a | n/a | |
| $52.3M | n/a | n/a | |
| $26.4M | n/a | n/a | |
| $22.5M | 0.3x | -154.5x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharmacies